Mechanisms regulating PKGI proteolysis and modulation of pulmonary SMC phenotype
调节 PKGI 蛋白水解和肺 SMC 表型调节的机制
基本信息
- 批准号:8452162
- 负责人:
- 金额:$ 41.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:Amino Acid SequenceAnimal ModelAntibodiesApplications GrantsBindingBlood VesselsBlood flowBreathingBronchopulmonary DysplasiaCell Differentiation processCell NucleusCell ProliferationCell physiologyCessation of lifeChildhoodCleaved cellCyclic AMP Response ElementCyclic AMP-Responsive DNA-Binding ProteinCyclic GMPDistalGasesGene ExpressionGolgi ApparatusGrowthGuanylate CyclaseHeart failureHumanHyperplasiaHypertensionIn VitroInfantInjuryLaboratoriesLeadLungMembraneMolecularMorbidity - disease rateNatriuretic PeptidesNewborn AnimalsNewborn InfantNitric OxideNuclearNuclear Localization SignalNuclear ProteinsPathway interactionsPatientsPeptide HydrolasesPeptide Signal SequencesPeripheralPhenotypePhosphorylationPhosphotransferasesPlayProprotein ConvertasesProteinsProteolysisProteolytic ProcessingPulmonary HypertensionPulmonary artery structurePulmonary vesselsRNA InterferenceRattusResearch Project GrantsResearch ProposalsRoleSignal TransductionSiteSmooth Muscle MyocytesTestingTransactivationVascular Diseasesactivating transcription factor 1basecGMP productioncGMP-dependent protein kinase Icongenital heart disorderenzyme activityimprovedinfant outcomeinhaled nitric oxideinhibitor/antagonistinjuredlung developmentlung injurymortalitymutantnovelnucleocytoplasmic transportpreventprotective effectpuptranscription factor
项目摘要
Injury of the developing lung often causes hyperplasia of peripheral pulmonary vascular smooth muscle
cells (SMC) and precocious muscularization of pulmonary vessels, thereby restricting lung blood flow and
causing pulmonary artery hypertension. Agents directed at increasing lung cGMP levels, such as inhaled
nitric oxide gas, have been observed to decrease abnormal pulmonary artery SMC proliferation and improve
injured newborn lung development in animal models. However, the protective effect of these therapies is
incomplete.
The long-term objective of this grant proposal is to further characterize the molecular mechanisms through
which cGMP regulates pulmonary artery SMC (PASMC) differentiation and proliferation. Cyclic GMP
modulates PASMC phenotype primarily by stimulating cGMP-dependent protein kinase I (PKGI). Emerging
evidence suggests that cGMP-stimulated PKGI nuclear localization and phosphorylation of nuclear proteins
and transcription factors, such as CREB and ATF-1, regulate SMC phenotype. Recently we observed that
cGMP-stimulated PKGI proteolysis generates a COOH-terminal constitutively active kinase fragment, PKGI¿,
that translocates to the nucleus of SMC and is critical for the transactivation of gene expression. Studies of the
PKGI proteolysis cleavage site and the effect of substrate decoys suggest that proprotein convertases are
responsible for PKGI¿ nuclear localization in SMC. However, the mechanisms regulating PKGI proteolysis and
PKGI¿ nuclear localization and the role of PKGI¿ in modulating SMC phenotype are unknown. Our central
hypothesis is that PKGI proteolysis and PKGI¿ nuclear localization are key determinants of nuclear PKGI
signaling and SMC differentiation and proliferation. We will test this hypothesis in rat PASMC in the following
aims. Specific aim 1 characterizes the specific role of proprotein convertases in regulating PKGI proteolysis
and nuclear PKGI signaling. We will use RNAi to identify which proprotein convertase(s) regulate PKGI
proteolysis. We will also use proprotein convertase inhibitors to test how these proteases regulate PASMC
differentiation and proliferation. Specific aim 2 examines the mechanisms that regulate the nuclear localization
of PKGI¿. The role of the Golgi apparatus in PKGI proteolysis and of active nuclear transport in PKGI¿ in
nuclear PKGI signaling will be evaluated. Specific aim 3 tests the functional significance of PKGI proteolysis
and nuclear PKGI¿ compartmentation in regulating PASMC differentiation and proliferation and tests whether
PKGI proteolysis is deficient in the injured developing lung.
The studies proposed in this grant application will provide novel information about the mechanisms
regulating cGMP-driven modulation of SMC phenotype. They are likely to identify pathways that may be
abnormal in vascular injury and to provide new targets for therapies directed at preventing pulmonary vascular
disease.
发育中肺的损伤通常会引起周围肺平滑肌的增生
细胞(SMC)和肺动脉壁的早熟肌肉化,从而限制肺血流和
引起肺动脉高压。指向肺CGMP水平增加的代理,例如继承
已经观察到一氧化氮气体可降低异常的肺动脉SMC增殖并改善
动物模型中的新生儿肺发育受伤。但是,这些疗法的受保护作用是
不完整。
该赠款提案的长期目标是通过
CGMP调节肺动脉SMC(PASMC)分化和增殖。循环GMP
通过刺激CGMP依赖性蛋白激酶I(PKGI)来调节PASMC表型。新兴
有证据表明,CGMP刺激的PKGI核定位和核蛋白的磷酸化
和转录因子(例如CREB和ATF-1)调节SMC表型。最近我们观察到
CGMP刺激的PKGI蛋白水解产生了COOH末端组成型活性激酶片段PKGI,,PKGI,
这将易位到SMC的核,对于基因表达的反式激活至关重要。研究
PKGI蛋白水解裂解位点和底物诱饵的作用表明提谋蛋白转化酶是
负责SMC中的核定位。但是,调查PKGI蛋白水解和
PKGI¿核定位和PKGI€在调节SMC表型中的作用尚不清楚。我们的中心
假设是PKGI蛋白水解和核定位是核PKGI的关键决定者
信号传导和SMC分化和增殖。我们将在下面的大鼠PASMC中检验该假设
目标。具体目标1表征了促蛋白转化酶在调节PKGI蛋白水解中的特定作用
和核PKGI信号传导。我们将使用RNAi识别哪种促蛋白转化酶调节PKGI
蛋白水解。我们还将使用促蛋白转化酶抑制剂测试这些蛋白酶如何调节PASMC
分化和增殖。特定的目标2检查调节核定位的机制
pkgi。高尔基体在PKGI蛋白水解和PKGI核转运中的作用
将评估核PKGI信号传导。特定目标3测试PKGI蛋白水解的功能意义
和核pkgi¿在确定PASMC分化和增殖方面的隔室,并测试是否测试
PKGI蛋白水解缺乏受伤的发育中的肺。
本赠款应用中提出的研究将提供有关机制的新信息
调节CGMP驱动的SMC表型调制。他们可能会确定可能是
血管损伤异常,为预防肺血管的疗法提供新靶标
疾病。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transglutaminase 2: a new player in bronchopulmonary dysplasia?
转谷氨酰胺酶 2:支气管肺发育不良的新参与者?
- DOI:10.1183/09031936.00075713
- 发表时间:2014
- 期刊:
- 影响因子:0
- 作者:Witsch,ThiloJ;Niess,Gero;Sakkas,Elpidoforos;Likhoshvay,Tatyana;Becker,Simone;Herold,Susanne;Mayer,Konstantin;Vadász,István;RobertsJr,JesseD;Seeger,Werner;Morty,RoryE
- 通讯作者:Morty,RoryE
The Golgi apparatus regulates cGMP-dependent protein kinase I compartmentation and proteolysis.
- DOI:10.1152/ajpcell.00199.2014
- 发表时间:2015-06
- 期刊:
- 影响因子:0
- 作者:S. Kato;Jingsi Chen;Katherine H Cornog;Huili Zhang;Jesse D. Roberts
- 通讯作者:S. Kato;Jingsi Chen;Katherine H Cornog;Huili Zhang;Jesse D. Roberts
Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia.
- DOI:10.1152/ajplung.00109.2013
- 发表时间:2014-02
- 期刊:
- 影响因子:0
- 作者:T. Witsch;P. Turowski;E. Sakkas;Gero Niess;S. Becker;S. Herold;K. Mayer;I. Vadász;Jesse D. Roberts-Jess
- 通讯作者:T. Witsch;P. Turowski;E. Sakkas;Gero Niess;S. Becker;S. Herold;K. Mayer;I. Vadász;Jesse D. Roberts-Jess
cGMP-dependent protein kinase I gamma encodes a nuclear localization signal that regulates nuclear compartmentation and function.
cGMP 依赖性蛋白激酶 I gamma 编码调节核区室和功能的核定位信号。
- DOI:10.1016/j.cellsig.2014.08.004
- 发表时间:2014
- 期刊:
- 影响因子:4.8
- 作者:Chen,Jingsi;RobertsJr,JesseD
- 通讯作者:RobertsJr,JesseD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JESSE D ROBERTS其他文献
JESSE D ROBERTS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JESSE D ROBERTS', 18)}}的其他基金
TGFB AND PULMONARY ALDEHYDES IN NEWBORN LUNG INJURY
TGFB 和肺醛在新生儿肺损伤中的作用
- 批准号:
10009822 - 财政年份:2019
- 资助金额:
$ 41.64万 - 项目类别:
TGFB and Nitric Oxide Signaling in Pediatric Pulmonary Vascular Disease
小儿肺血管疾病中的 TGFB 和一氧化氮信号传导
- 批准号:
9301313 - 财政年份:2015
- 资助金额:
$ 41.64万 - 项目类别:
TGFB and Nitric Oxide Signaling in Pediatric Pulmonary Vascular Disease
小儿肺血管疾病中的 TGFB 和一氧化氮信号传导
- 批准号:
9127330 - 财政年份:2015
- 资助金额:
$ 41.64万 - 项目类别:
Mechanisms regulating PKGI proteolysis and modulation of pulmonary SMC phenotype
调节 PKGI 蛋白水解和肺 SMC 表型调节的机制
- 批准号:
8235019 - 财政年份:2010
- 资助金额:
$ 41.64万 - 项目类别:
Mechanisms regulating PKGI proteolysis and modulation of pulmonary SMC phenotype
调节 PKGI 蛋白水解和肺 SMC 表型调节的机制
- 批准号:
7885712 - 财政年份:2010
- 资助金额:
$ 41.64万 - 项目类别:
Mechanisms regulating PKGI proteolysis and modulation of pulmonary SMC phenotype
调节 PKGI 蛋白水解和肺 SMC 表型调节的机制
- 批准号:
8041066 - 财政年份:2010
- 资助金额:
$ 41.64万 - 项目类别:
Mechanisms of PKG-induced PASMC Differentiation
PKG诱导PASMC分化的机制
- 批准号:
7212065 - 财政年份:2005
- 资助金额:
$ 41.64万 - 项目类别:
Mechanisms of PKG-induced PASMC Differentiation
PKG诱导PASMC分化的机制
- 批准号:
7053386 - 财政年份:2005
- 资助金额:
$ 41.64万 - 项目类别:
Mechanisms of PKG-induced PASMC Differentiation
PKG诱导PASMC分化的机制
- 批准号:
6908451 - 财政年份:2005
- 资助金额:
$ 41.64万 - 项目类别:
Mechanisms of PKG-induced PASMC Differentiation
PKG诱导PASMC分化的机制
- 批准号:
7414082 - 财政年份:2005
- 资助金额:
$ 41.64万 - 项目类别:
相似国自然基金
TLR4调控系统性红斑狼疮中自身反应性B-1a细胞活化的作用及机理研究
- 批准号:81901635
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
IL-17促进系统性红斑狼疮发病中浆细胞功能的机制研究
- 批准号:81771761
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
中东呼吸综合征新型人源应急救治单克隆抗体保护作用机制研究
- 批准号:81772191
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
肺腺癌中Timp-1促癌机制的研究及其阻断抗体的运用
- 批准号:81672268
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
抗磷脂抗体诱导中性粒细胞释放NETs致抗磷脂综合征肾病的机制研究
- 批准号:81671589
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Bio-Responsive and Immune Protein-Based Therapies for Inhibition of Proteolytic Enzymes in Dental Tissues
用于抑制牙齿组织中蛋白水解酶的基于生物响应和免疫蛋白的疗法
- 批准号:
10555093 - 财政年份:2023
- 资助金额:
$ 41.64万 - 项目类别:
Foxp3 isoforms and IgE-mediated UVB-induced skin inflammation expression
Foxp3亚型和IgE介导的UVB诱导的皮肤炎症表达
- 批准号:
10728256 - 财政年份:2023
- 资助金额:
$ 41.64万 - 项目类别:
Developing a PIV5-based human metapneumovirus (HMPV) vaccine
开发基于 PIV5 的人类偏肺病毒 (HMPV) 疫苗
- 批准号:
10698491 - 财政年份:2023
- 资助金额:
$ 41.64万 - 项目类别:
Gain-of-function complement activators as a new class of immunotherapeutic molecules
功能获得性补体激活剂作为一类新型免疫治疗分子
- 批准号:
10629623 - 财政年份:2023
- 资助金额:
$ 41.64万 - 项目类别:
Semantic integration of protein epitopes and functional features for infectious and autoimmune disease knowledge discovery
用于传染病和自身免疫性疾病知识发现的蛋白质表位和功能特征的语义整合
- 批准号:
10442059 - 财政年份:2022
- 资助金额:
$ 41.64万 - 项目类别: